The latest (October 17th) issue, of the leading medical journal, The Lancet, provides the most detailed analyses and ratings ever, of the healthcare that is provided in each of 204 countries. These ratings are based on a comprehensive set of 42 ratios, such as, “Mortality from breast cancer for females aged 20–64 years” divided by “Incidence of breast cancer for females aged 20–64 years.” All 42 ratios are effectiveness-of-treatment measures. That is the only scientific way to measure the quality of a nation’s healthcare.
Here, in order, are the top 113 countries, those that score above 54, on a scale where the top score is 96 and the bottom score is 22 — which latter country (not shown here) is Central African Republic, which rated 1 or 0, totally lacking, on a number of categories. These 113 countries are listed according to their total score. So, any country that isn’t listed here can reasonably be considered to have very poor quality medical care:
SCORE: COUNTRY (and rank)
96: Japan — world’s best medical care
95: Iceland — world’s second-best medical care
94: Norway — world’s third-best medical care
93: San Marino, Switzerland
92: Andorra, Singapore
91: Finland, France, Luxembourg, Monaco
90: Canada, Ireland, Netherlands, Slovenia, Spain, Sweden
89: Australia, Italy, South Korea
88: UK (ranked as #21)
87: Belgium (#22)
86: Austria, Germany
84: Denmark, Portugal
83: Malta, N.Z.
82: Czech Republic, Estonia, Kuwait, USA
81: Israel (#33)
80: Cyprus, Greece, Qatar
79: Costa Rica, Croatia, Taiwan
78: Bermuda (#40)
76: Peru, Puerto Rico
75: Lebanon (#43)
74: Chile, Colombia
73: Cuba, Poland
72: Hungary, Thailand
71: Oman, Panama
70: Albania, China, Iran, Jordan, Latvia, Lithuania, Romania
69: Greenland, Russia, Turkey, Uruguay
68: Tunisia (#63)
67: Malaysia, Maldives
66: Brunei, Libya, Montenegro, Sri Lanka
65: Brazil (#70)
64: Bosnia, Ecuador, Guam, Saudi Arabia
63: Bulgaria, Paraguay, Serbia, UAE
62: Armenia, Cape Verde, Cook Islands, El Salvador, Moldova, Namibia, Seychelles
61: Argentina, Bahamas, Barbados, Bahrain, Mexico, North Macedonia, Palestine, Venezuela
60: Antigua, Northern Mariana Islands, South Africa, Vietnam
59: Kazakhstan, Rwanda, St. Lucia
58: Botswana, Iraq, Morocco, Syria
57: Jamaica, Nicaragua, Ukraine
56: Georgia, Malawi, Mauritius, Trinidad
55: Philippines, Sao Tome
To find the fields of strength and of weakness in the healthcare that is provided in each country, see the tables that are presented on pages 11-16 of the pdf of the article, which pages also show the detailed ratings of each of the 204 nations’ medical care. However, that article provides no rankings, but only scores. The rankings that are shown in the present article are derived from the scores in that article, but are not shown in that article. That article presents the countries only in alphabetical order: it provides no rank-order of them. For example: the United States was one of the four countries that were ranked lower than 28 countries, such that the next lower-ranked country, after those four, Israel, ranked as being #33; and, therefore, the U.S. ranked somewhere among #s 29 and 32 among the 204 nations, or, roughly, as being ranked as number 30 or 31.
Delta variant, a warning the COVID-19 virus is getting ‘fitter and faster’
Cases and deaths resulting from COVID-19 continue to climb worldwide, mostly fuelled by the highly transmissible Delta variant, which has spread to 132 countries, said the head of the World Health Organization (WHO) on Friday.
Almost 4 million cases worldwide were reported last week to WHO and the agency expects the total number of cases to pass 200 million, in the next two weeks.
“And we know this is an underestimate”, underscored Director-General Tedros Adhanom Gebreyesus during his regular COVID-19 briefing.
Infections have increased in every region of the world, with some even reaching 80 per cent more in the past month. In Africa, deaths have increased by 80 per cent over the same period, the official warned.
Tedros blamed the rise of cases on increased social mixing and mobility, the inconsistent use of public health and social measures, and inequitable vaccine use. He said “hard-won gains” are in jeopardy or being lost, and health systems in many countries are increasingly overwhelmed.
“WHO has warned that the COVID-19 virus has been changing since it was first reported, and it continues to change. So far, four variants of concern have emerged, and there will be more as long as the virus continues to spread”, he underscored.
A higher viral load
Lead WHO epidemiologist and COVID-19 technical lead, Dr. Maria Van Kerkhove, explained that the Delta variant has certain mutations that allow the virus to adhere to human cells more easily and that experts are also seeing a higher viral load in individuals infected.
She called Delta “dangerous and the most transmissible SARS-CoV-2 virus to date”.
“There are some laboratory studies that suggest that there’s increase replication in some of the modelled human airway systems”, she added.
In terms of severity, Dr. Van Kerkhove highlighted that there has been an increase in hospitalizations in certain countries affected by the variant, “but we haven’t yet seen an increase in mortality”.
The WHO expert reminded that although there is some data that suggest that people vaccinated can get infected and transmit the variant, the likelihood is much reduced after the second dose has been administered and reached full effectiveness.
She also clarified that Delta is not specifically targeting children as some reports have suggested, but warned that as long as the variants are circulating, they will infect anybody that is not taking proper precautions.
Continuing to evolve
“It’s in the virus’s interests to evolve, viruses are not alive they don’t have a brain to think through this, but they become more fit the more they circulate, so the virus will likely become even more transmissible because this is what viruses do, they evolve they change overtime”, Dr. Van Kerkhove warned, echoing Tedros’ remarks.
“We have to do what we can to drive it down”, she added, reminding that public health and social measures do work against the Delta variant, and that the vaccines do prevent disease and death.
Dr. Michael Ryan, Executive Director of WHO Health Emergencies, said that even with the virus getting “faster and fitter” the gameplan does not change, but It needs to be implemented more efficiently.
“Delta is a warning that this virus is evolving, but it is also a call to action before more dangerous variants emerge”, he said.
Shots for Africa
Last month, the WHO chief announced the setting up of a technology transfer hub for mRNA vaccines In South Africa as part of WHO’s efforts to scale up production of vaccines and their distribution in Africa.
“Today we have taken another step forward, with a letter of intent that sets out the terms of collaboration signed by the partners in the hub: WHO; the Medicines Patent Pool; Afrigen Biologics; the Biologicals and Vaccines Institute of Southern Africa; the South African Medical Research Council and the Africa Centres for Disease Control and Prevention”, Tedros explained.
He added that WHO’s goal remains to aid every country in vaccinating at least 10% of its population by the end of September, at least 40% by the end of this year, and 70% by the middle of next year.
“We are a long way off achieving those targets. So far, just over half of countries have fully vaccinated 10% of their population, less than a quarter of countries have vaccinated 40%, and only 3 countries have vaccinated 70%”, Tedros warned.
The WHO head reminded that the global distribution of vaccines remains unjust, despite expert warnings and appeals, and said that all regions remain at risk, “none more so, than Africa”.
“On current trends, nearly 70% of African countries will not reach the 10% vaccination target by the end of September”, he cautioned.
New tool to fight Delta
Tedros also announced that on response to the Delta surge, the WHO’s Access to COVID-19 Tools Accelerator is launching the Rapid ACT-Accelerator Delta Response, or RADAR, and issuing an urgent call for 7.7 billion U.S. dollars for tests, treatments and vaccines.
COVAX and World Bank to Accelerate Vaccine Access for Developing Countries
COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the fully donor-subsidized doses they are already receiving from COVAX.
COVAX will now be able to make advance purchases from vaccine manufacturers based on aggregated demand across countries, using financing from the World Bank and other multilateral development banks. Participating developing countries will have greater visibility of available vaccines, quantities available, and future delivery schedules, enabling them to secure doses earlier, and prepare and implement vaccination plans more effectively.
“This important and timely financing mechanism, made possible now by the World Bank and Gavi teaming up on the AMC cost-sharing arrangement, will allow COVAX to unlock additional doses for low- and middle-income countries,” said Dr. Seth Berkley, CEO, Gavi, the Vaccine Alliance. “As we move beyond initial targets and work to support countries’ efforts to protect increasingly large portions of their populations, World Bank financing will help us advance further towards our goal of bringing COVID-19 under control.”
The scalable mechanism brings together COVAX’s ability to negotiate advance purchase agreements with vaccine manufacturers with the World Bank’s ability to provide predictable financing to countries for vaccine purchase, deployment and broader health systems investments. The new mechanism will mitigate risks and uncertainties in country demand and financing ability.
“Accessing vaccines remains the single greatest challenge that developing countries face in protecting their people from the health, social, and economic impacts of the COVID-19 pandemic,” said World Bank Group President David Malpass. “This mechanism will enable new supplies and allow countries to speed up the purchase of vaccines. It will also provide transparency about vaccine availability, prices, and delivery schedules. This is crucial information as governments implement their vaccination plans.”
Countries with approved World Bank vaccine projects that confirm the purchase of additional doses through COVAX will agree with COVAX on the number of doses of a specific vaccine as well as related windows of delivery. On receiving a request from the country, the World Bank will provide COVAX a payment confirmation, allowing COVAX to make advance purchases of large amounts of vaccine doses with manufacturers at competitive prices.
Under the cost-sharing arrangement for AMC countries (92 low- and middle-income countries), COVAX plans to make available up to 430 million additional doses, or enough to fully vaccinate 250 million people, for delivery between late 2021 and mid-2022. There will be several supply offerings where countries will have the opportunity to select and commit to procuring specific vaccines that align with their preferences.
COVAX is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the World Health Organization (WHO). The World Bank and COVAX will work in partnership with UNICEF and the PAHO Revolving Fund as key implementing partners to ensure safe vaccine delivery and supply of materials such as syringes, safety boxes and other items essential for vaccination campaigns.
Study Finds That India Might Have Half Of All Covid-19 Deaths Worldwide
On July 20th, an analysis that was published of India’s “excess mortality estimates from three different data sources from the pandemic’s start through June 2021 … yields an estimate of 4.9 million excess deaths.” As-of July 20th, the total number of deaths that had been officially reported worldwide from Covid-19 was 4,115,391, and only 414,513 (10%) of those were in India. If this new study is correct, then the possibility exists that around half of all deaths that have occurred, thus far, from Covid-19, could be in India, not merely the currently existing 10% that’s shown in the official figures.
This study doesn’t discuss why the actual number of deaths in India from Covid-19 might be around ten times higher than the official Indian figures, but one reason might be a false attribution of India’s greatly increased death-rate from the Covid-19 epidemic not to Covid-19 but to other causes, such as to Covid-19-related illnesses.
The new study is titled “Three New Estimates of India’s All-Cause Excess Mortality during the COVID-19 Pandemic”, and the detailed version of it can be downloaded here. The study was funded by U.S.-and-allied billionaires and their foundations and corporations, and by governments that those billionaires also might control. However, this doesn’t necessarily mean that its methodology is in any way unscientific or otherwise dubious. The study raises serious questions — it does not, in and of itself, answer any. It’s a serious scientific study.
On 1 August 2020, I headlined “India and Brazil Are Now the Global Worst Coronavirus Nations”, and reported that, “India and Brazil have now overtaken the United States as the world’s worst performers at controlling the cononavirus-19 plague. The chart of the numbers of daily new cases in India shows the daily count soaring more than in any other country except Brazil, whereas in the United States, the daily number of new cases has plateaued ever since it hit 72,278 on July 10th, three weeks ago.” At that time, there was great pressure upon India’s Government to stop the alarming acceleration in the daily numbers of people who were officially counted as being patients (active cases) from the disease, and of dying from it. One way that a government can deal with such pressures is by mis-classifying cases, and deaths, from a disease, as being due to other causes, instead.
India’s Opportunity to Become a Global Manufacturing Hub
Beyond the unprecedented health impact, the COVID‑19 pandemic has been catastrophic for the global economy and businesses and is disrupting...
IRENA and the ESA Agree to Advance Energy Transition in Space Activities
The International Renewable Energy Agency (IRENA) and the European Space Agency (ESA) signed a Memorandum of Understanding (MoU) today to...
The Allure Of Winning
The Tokyo 2021 Olympics are in full swing a year off schedule, and still marred by the Covid menace. The...
Why climate science is key to protecting people and planet
This week, scientists and representatives from 195 countries are gathered at the 54th Session of the Intergovernmental Panel on Climate...
Hungary: Reforms to raise productivity would strengthen recovery from COVID-19
Hungary’s economy is emerging from the crisis caused by COVID-19, yet sustaining the country’s robust pre-pandemic levels of growth will...
The problems of climate change, part 2
As we continue to examine the studies on climate change that is raising the average temperature of the planet, it...
UNEP West Asia launches the State of Food Waste Report
Improved awareness, appropriate policies and a strong regulatory framework are needed to reduce food waste in West Asia, according to...
Defense2 days ago
The Future of The Quadrilateral Security Dialogue (the QUAD) Grouping Explained
Green Planet2 days ago
Wildfires in Turkish tourist regions are the highest recorded
South Asia2 days ago
India’s North East: A cauldron of resentment
South Asia1 day ago
Why Strategies of Stakeholders in Afghanistan Failing Against Taliban?
East Asia1 day ago
Belt & Road ABCs: Analysis of “One Belt – One Road” initiative
Development2 days ago
Moscow is in the Top7 Intelligent Communities in the world
Africa2 days ago
Russia and China: Geopolitical Rivals and Competitors in Africa
Health & Wellness2 days ago
Delta variant, a warning the COVID-19 virus is getting ‘fitter and faster’